Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 20 Nov 23 424B3 Prospectus supplement
- 24 Oct 23 424B3 Prospectus supplement
- 23 Oct 23 EFFECT Notice of effectiveness
- 17 Oct 23 S-1/A IPO registration (amended)
- 5 Oct 23 S-1/A IPO registration (amended)
-
11 Apr 23 S-1/A IPO registration (amended)
- 1 Feb 23 S-1/A IPO registration (amended)
- 21 Dec 22 S-1 IPO registration
ZVSA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 31, 2023, in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-268934) and related Prospectus of ZyVersa Therapeutics, Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
Orlando, Florida
April 11, 2023